ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
-10.89%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$378M
AUM Growth
+$378M
(+4.4%)
Cap. Flow
+$78.7M
Cap. Flow
% of AUM
20.82%
Top 10 Holdings %
Top 10 Hldgs %
70.94%
Holding
39
New
6
Increased
17
Reduced
5
Closed
7
Top Buys
Top Sells
| 1 |
Celldex Therapeutics
CLDX
|
$8.89M |
| 2 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$5.67M |
| 3 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$5.58M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$5.04M |
| 5 |
Amicus Therapeutics
FOLD
|
$4.76M |
Sector Composition
| 1 | Healthcare | 91.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amicus Therapeutics
FOLD
$2.34B
| $59.5M | 15.46% | 4,250,199 -340,000 | -7% | -$4.76M |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $50M | 13% | 1,453,055 +453,055 | +45% | +$15.6M |
|
3
Vanda Pharmaceuticals
VNDA
$279M
| $24M | 6.23% | 2,124,593 +685,900 | +48% | +$7.74M |
|
|
NDRM
4
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $22.8M | 5.93% | 1,103,093 +731,982 | +197% | +$15.1M |
|
|
LJPC
5
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $22.4M | 5.81% | 804,299 +192,300 | +31% | +$5.34M |
|
6
Acadia Pharmaceuticals
ACAD
$4.38B
| $19.2M | 5% | 581,900 +86,900 | +18% | +$2.87M |
|
|
PTX
7
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $19M | 4.93% | 6,004,564 +4,754,397 | +380% | +$15M |
|
8
Iovance Biotherapeutics
IOVA
$807M
| $18.3M | 4.76% | 3,180,913 +257,848 | +9% | +$1.49M |
|
|
SRNE
9
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $18.1M | 4.69% | 2,151,437 -35,083 | -2% | -$294K |
|
|
CASC
10
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $15.1M | 3.92% | 5,506,618 -110,385 | -2% | -$302K |
|
11
Sarepta Therapeutics
SRPT
$1.78B
| $15.1M | 3.92% | +469,025 | New | +$15.1M |
|
|
TLGT
12
DELISTED
Teligent, Inc
TLGT
| $11.6M | 3.03% | 1,779,782 +26,100 | +1% | +$171K |
|
|
AEGR
13
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $11M | 2.85% | +806,300 | New | +$11M |
|
|
AGEN
14
Agenus
AGEN
$133M
| $10.1M | 2.63% | 2,199,137 | – | – |
|
|
DERM
15
DELISTED
Dermira, Inc.
DERM
| $8.48M | 2.2% | +363,250 | New | +$8.48M |
|
|
SPPI
16
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $7.87M | 2.05% | +1,315,600 | New | +$7.87M |
|
17
ImmunityBio
IBRX
$2.21B
| $7.3M | 1.9% | +728,887 | New | +$7.3M |
|
|
INNL
18
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
| $6.29M | 1.64% | 502,422 +5,000 | +1% | +$62.6K |
|
|
EGLT
19
DELISTED
Egalet Corporation
EGLT
| $5.81M | 1.51% | +440,606 | New | +$5.81M |
|
|
SIOX
20
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $5.25M | 1.37% | 406,470 +66,470 | +20% | +$859K |
|
21
Veracyte
VCYT
$2.39B
| $3.62M | 0.94% | 772,297 +13,800 | +2% | +$64.7K |
|
|
TRIL
22
DELISTED
Trillium Therapeutics Inc.
TRIL
| $3.35M | 0.87% | 255,097 +160,697 | +170% | +$2.11M |
|
23
Fortress Biotech
FBIO
$76.8M
| $3.32M | 0.86% | 1,275,521 +345,990 | +37% | +$899K |
|
24
Vericel Corp
VCEL
$1.83B
| $3.08M | 0.8% | 1,135,120 +51,634 | +5% | +$140K |
|
|
ADYX
25
DELISTED
Adynxx, Inc. Common Stock
ADYX
| $2.7M | 0.7% | 850,000 +50,000 | +6% | +$159K |
|